[#item_full_content] MMJ International Holdings spent the better part of a decade fighting the DEA to develop cannabis medicine the FDA way. Now it’s in court trying to undo the rescheduling that gave state operators an easier path, a move that could drag the whole industry back to Schedule I.  Read More